Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

FDA clears software that analyzes lung function in COVID patients from single x-ray

Australia-based 4DMedical said the software can also assist in assessing patients with asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung cancer. 

Thumbnail

Novel ‘double-contrast’ method spots small tumors on MRI

University of California, Davis, researchers believe their new probe could help detect very small, early stage tumors.

Thumbnail

NIH hands out $3.5M grant for PET-based research into depression

Stony Brook University investigators seek to quantify the precise degree of brain inflammation in those with the illness and ultimately hope to suggest novel treatments.

Thumbnail

FDA clears ‘world’s first’ ultrawide-bore MR for imaging obese or claustrophobic patients

United Imaging announced the approval on Tuesday, touting its uMR Omega system’s 75-centimeter bore and quick scan times. 

Thumbnail

RSNA 2020 annual meeting will be held virtually amid COVID-19 concerns

Since its inception, RSNA's in-person annual meeting has only been canceled twice, in 1943 and 1945, due to transportation and gasoline supply issues during and immediately following World War II.

Thumbnail

Company touts novice-guided ultrasound system to remotely monitor COVID-19 patients

The Butterfly Network said such telemedicine-based imaging was made possible by recent rule-relaxing from the Food and Drug Administration. 

Thumbnail

University spinoff receives $750K to develop iron-based alternative to gadolinium contrasts

Ferric Contrast, a contrast agent company founded by faculty from the University at Buffalo in New York, says doctors and patients want new options in MR imaging.

Thumbnail

Researchers ID potentially treatable genetic mutation target for therapy-resistant prostate cancer

German scientists found six of seven patients with difficult-to-treat cancer had genetic mutations in their DNA damage-repair genes, according to new research.